医药前沿
醫藥前沿
의약전연
YIAYAO QIANYAN
2014年
36期
83-84
,共2页
胃溃疡%3联用药%临床疗效%安全性
胃潰瘍%3聯用藥%臨床療效%安全性
위궤양%3련용약%림상료효%안전성
gastric ulcer%3 associated medication%clinical efficacy%safety
目的:研究探讨在胃溃疡患者中使用三联药物进行治疗的临床效果,并对药物使用的安全性进行评价。方法:选取就诊于我院的胃溃疡患者134例,根据治疗所使用药物的不同进行随机分组:观察组、对照组,每组分别有67例患者,对照组使用单药进行治疗,观察组使用3联药物进行治疗。治疗后,观察患者的临床疗效及不良反应的发生情况。结果:观察组的治疗效果要显著优于对照组(P<0.05);观察组患者的不良反应发生情况要显著少于对照组(P<0.05)。结论:在胃溃疡患者中使用三联药物进行治疗,取得了较好的临床疗效,并且具有不良反应少的优点,因此,在临床治疗胃溃疡过程中,要积极的使用三联用药进行治疗。
目的:研究探討在胃潰瘍患者中使用三聯藥物進行治療的臨床效果,併對藥物使用的安全性進行評價。方法:選取就診于我院的胃潰瘍患者134例,根據治療所使用藥物的不同進行隨機分組:觀察組、對照組,每組分彆有67例患者,對照組使用單藥進行治療,觀察組使用3聯藥物進行治療。治療後,觀察患者的臨床療效及不良反應的髮生情況。結果:觀察組的治療效果要顯著優于對照組(P<0.05);觀察組患者的不良反應髮生情況要顯著少于對照組(P<0.05)。結論:在胃潰瘍患者中使用三聯藥物進行治療,取得瞭較好的臨床療效,併且具有不良反應少的優點,因此,在臨床治療胃潰瘍過程中,要積極的使用三聯用藥進行治療。
목적:연구탐토재위궤양환자중사용삼련약물진행치료적림상효과,병대약물사용적안전성진행평개。방법:선취취진우아원적위궤양환자134례,근거치료소사용약물적불동진행수궤분조:관찰조、대조조,매조분별유67례환자,대조조사용단약진행치료,관찰조사용3련약물진행치료。치료후,관찰환자적림상료효급불량반응적발생정황。결과:관찰조적치료효과요현저우우대조조(P<0.05);관찰조환자적불량반응발생정황요현저소우대조조(P<0.05)。결론:재위궤양환자중사용삼련약물진행치료,취득료교호적림상료효,병차구유불량반응소적우점,인차,재림상치료위궤양과정중,요적겁적사용삼련용약진행치료。
Objective To investigate the use of triple-drug therapy in patients with gastric ulcer clinical effects, and safety of drug use were evaluated. Methods 134 patients received treatment in hospital for stomach ulcers, according to the use of drugs in the treatment of different random groups: observation group and control group were 67 patients in the control group were treated with a single drug, the use of the observation group 3 United drug. After treatment, the observed incidence of clinical efficacy and adverse reactions in patients. The results of treatment effect of the observation group was significantly better than the control group (P <0.05); adverse reactions were observed in the incidence of patients was significantly less than the control group (P <0.05). Conclusion In patients with gastric ulcer in the triple drug therapy, achieved good clinical efficacy, and has the advantage of fewer adverse reactions, therefore, in the clinical treatment of gastric ulcer process, to actively use triple drug treatment.